| Trial ID: | L7229 |
| Source ID: | NCT00609154
|
| Associated Drug: |
Glucagon Like Peptide-1
|
| Title: |
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00609154/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: glucagon like peptide-1|DIETARY_SUPPLEMENT: glucose control
|
| Outcome Measures: |
Primary: Insulin Biosynthesis Rate, Blood insulin biosynthesis rate, 24 hours |
|
| Sponsor/Collaborators: |
Sponsor: Albert Einstein College of Medicine | Collaborators: Merck Sharp & Dohme LLC|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-08-12
|
| Completion Date: |
2014-05-13
|
| Results First Posted: |
2024-02-28
|
| Last Update Posted: |
2024-02-28
|
| Locations: |
Albert Einstein College of Medicinie, Bronx, New York, 10461, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00609154
|
